CVKD: Designing Phase 3 Trial for CAD-1005 in HIT

CVKD READ THE FULL CVKD RESEARCH REPORT Business Update Planning for Phase 3 Registration Trial of CAD-1005 in HIT On April ...

Cadrenal Therapeutics Reports First Quarter 2026 Financial Results and Provides Phase 3 Development Update on CAD-1005 Following End-of-Phase 2 Meeting with FDA

Official FDA meeting minutes and Phase 2 data provide guidance on the pivotal Phase 3 registration path for CAD-1005 in heparin-induced thrombocytopenia (HIT)PONTE VEDRA, Fla., May 07, 2026 (GLOBE ...

Moderna stock rises on positive phase 3 flu data: What investors need to know

Moderna Inc MRNA shares are trading higher Friday morning as traders react to peer reviewed Phase 3 flu-vaccine data. Here’s ...
CIDRAP

Phase 3 trial finds Moderna mRNA flu vaccine outperforms standard vaccine in older adults

The findings arrive after a swirl of regulatory uncertainty surrounding the trivalent (three-strain) vaccine, mRNA-1010.

Artiva Biotherapeutics: 'Buy' On AlloNK POC And FDA Phase 3 Alignment For Refractory RA

Artiva Biotherapeutics (ARTV) is maintained as a "Buy," driven by FDA alignment for a single phase 3 trial of AlloNK plus ...
Fierce Biotech

Celcuity’s gedatolisib beats Novartis’ Piqray in phase 3 breast cancer study

Celcuity plans to submit the data to the FDA as a supplemental new drug application. If everything goes to plan, the FDA will ...
Fierce Biotech

Viridian’s Tepezza rival racks up second phase 3 win, clearing path to FDA

In March, Viridian posted a phase 3 win for elegrobart in active TED, defined as patients who developed symptoms within 15 ...